Core Viewpoint - The company is focusing on the commercialization of synthetic biology products, which are currently in a ramp-up phase of production, with improved order conditions compared to the previous year [1] Group 1: Synthetic Biology Products - The synthetic biology products currently in mass production include resveratrol, 5-hydroxytryptophan, ergothioneine, squalene, and inositol [1] - As of the third quarter of 2025, the revenue from synthetic biology products is projected to be 44.8 million yuan [1] - The company adheres to a dual-driven strategy of "biological fermentation + synthetic biology" to continuously optimize production processes [1] Group 2: Production Capacity and Orders - The synthetic biology base is still in the capacity ramp-up phase [1] - There has been an improvement in order conditions compared to the same period last year [1] - The company is actively promoting the commercialization process of synthetic biology products [1]

Core Viewpoint - The company is focusing on the commercialization of synthetic biology products, with a dual strategy of "biological fermentation + synthetic biology" to optimize production processes and improve order conditions compared to the previous year [1] Group 1: Synthetic Biology Products - Current mass-produced synthetic biology products include red yeast rice, 5-hydroxytryptophan, ergothioneine, squalene, and inositol [1] - By the third quarter of 2025, the revenue from synthetic biology products is projected to reach 44.8 million yuan [1] Group 2: Production Capacity and Strategy - The synthetic biology base is still in the capacity ramp-up phase this year [1] - The company is committed to continuously optimizing production processes and actively promoting the commercialization of synthetic biology products [1]